← Back to Search

Pre-Surgical Toolkit for Cancer Care

Stevens Point, WI
N/A
Waitlist Available
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be able to speak and complete questionnaires in English
Patients must have known or suspected cancer diagnosis and have one of the following cancer-directed operations planned: Gastrectomy, Colectomy, Proctectomy, Esophagectomy, Pancreatectomy, Hepatectomy, Total cystectomy, Partial or total nephrectomy, Lung lobectomy/pneumonectomy
Must not have
Patients under active treatment such as chemotherapy, targeted therapy, immunotherapy, radiation treatment, etc. for second primary, are not eligible
Patients undergoing emergent surgery are not eligible
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day of surgical consult
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a toolkit to improve surgical care and outcomes for elderly cancer patients. The toolkit may help improve patients' recovery rate and functioning after surgery.

See full description
Who is the study for?
This trial is for older adults with cancer who are planning to undergo major surgery like liver resection or lung lobectomy. They should be aiming for a cure, able to speak English, and complete questionnaires. Those with emergency surgeries, active treatment for another primary cancer, palliative intent, or mental impairments that prevent informed consent are not eligible.Check my eligibility
What is being tested?
The study tests a pre-surgical toolkit called OPTI-Surg designed to improve recovery and functioning after surgery in elderly cancer patients. It includes pre-surgery recommendations and coaching to help participants better prepare for their upcoming surgical procedures.See study design
What are the potential side effects?
Since this intervention involves informational material and coaching rather than medication or invasive procedures, typical medical side effects are not expected. However, there may be psychological impacts from receiving additional information about surgical care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can speak English and fill out forms in English.
 show original
Select...
I am scheduled for surgery to remove cancer from my stomach, colon, rectum, esophagus, pancreas, liver, bladder, kidney, or lung.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not currently receiving treatment for a second type of cancer.
 show original
Select...
I am not having emergency surgery.
 show original
Select...
I do not have a second type of cancer.
 show original
Select...
I am not having surgery to relieve symptoms for my spread cancer.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Physical Function 8 Weeks Post-surgery as Measured by the Caloric Expenditure Scale Per Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire
Secondary study objectives
Compliance Rate With Administration of Edmonton Frail Scale (EFS)
Percentage of Participants With Postoperative Complications (Clavien-Dindo Grades I-V)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Arm III (OPTI-Surg training and materials, coach)Experimental Treatment2 Interventions
Healthcare providers/institutions receive OPTI-Surg training and informational materials and meet with a coach.
Group II: Arm II (OPTI-Surg training and materials)Experimental Treatment2 Interventions
Healthcare providers/institutions receive OPTI-Surg training and informational materials.
Group III: Arm I (usual care)Active Control2 Interventions
Healthcare providers/institutions perform usual care.

Find a Location

Closest Location:Miami Valley Hospital South· Centerville, OH· 10 miles

Who is running the clinical trial?

Alliance for Clinical Trials in OncologyLead Sponsor
519 Previous Clinical Trials
221,959 Total Patients Enrolled
National Cancer Institute (NCI)NIH
14,057 Previous Clinical Trials
41,149,116 Total Patients Enrolled
George J. Chang, MD, MSStudy ChairThe University of Texas MD Anderson Cancer Center

Media Library

Pre-Surgical Toolkit (OPTI-Surg) Clinical Trial Eligibility Overview. Trial Name: NCT03857620 — N/A
Cancer Research Study Groups: Arm II (OPTI-Surg training and materials), Arm III (OPTI-Surg training and materials, coach), Arm I (usual care)
Cancer Clinical Trial 2023: Pre-Surgical Toolkit (OPTI-Surg) Highlights & Side Effects. Trial Name: NCT03857620 — N/A
Pre-Surgical Toolkit (OPTI-Surg) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03857620 — N/A
~49 spots leftby Mar 2026